What is Teleflex's market cap?

Teleflex (TFX) has a market capitalization of $5.8B and trades on NYSE.

What is Teleflex's revenue and profitability?

Teleflex generated $2.1B in trailing twelve-month revenue with a net loss of $1.0B, representing a net margin of -47.4%. Gross margin stands at 38.2%, with free cash flow of $122.3M. These figures are based on the Q1 2026 filing.

Who are Teleflex's competitors?

Teleflex's key competitors include Medtronic plc, Boston Scientific Corporation, Becton, Dickinson and Company, and others. These companies compete in similar markets and product categories.

Who does Teleflex partner with?

Teleflex's notable partners include Medline Industries, Inc., Montagu, Kohlberg & Company, and others.

What subsidiaries does Teleflex have?

Teleflex's subsidiaries include BIOTRONIK SE & Co. KG (Vascular Intervention business).

Where is Teleflex headquartered?

Teleflex is headquartered in United States of America and employs approximately 14,500 people. It has been publicly traded since 1972.

Teleflex

TFX

Teleflex Incorporated is a global provider of medical technology products focused on critical care and surgical applications.

Market cap

$5.8B+15.3%

Revenue$2.1B+25.0%

Net income-$1.0B-775%

Free cash flow$122.3M-69.0%

EPS (diluted)-$22.80-815%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 7, 2026

Revenue$548.3MBeat by $11.4M EPS$1.39Beat by $0.18

Read the full report

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$559.0M

EPS estimate$1.28

Financials

Q1 2026

Income statement

See full

Revenue$548.3M+32.3%

Gross profit$307.4M+20.4%

Operating income$20.2M-73.4%

Net income-$8.2M-109%

EPS (diluted)-$0.18-109%

Balance sheet

See full

Cash & equivalents$329.6M+16.8%

Total debt$2.8B+38.6%

Total equity$3.1B-24.7%

Total assets$6.8B-5.3%

Cash flow

See full

Operating cash flow$46.7M+68.3%

CapEx$18.8M-22.1%

Free cash flow$27.9M+676%

Valuation & ratios

Valuation

See full

Market cap$5.8B+15.3%

Enterprise value$8.25B+21.0%

P/S2.7×-0.2×

Profitability

See full

Gross margin38.2%-3.0pp

Operating margin3%-11.8pp

Net margin-47.4%-56.2pp

Returns & leverage

See full

Return on equity-28.1%-31.6pp

Debt / equity0.9×+0.4×

Current ratio2.6×+0.3×

Segments

By segment

See full

Americas$332.7M+14.8%

EMEA$146.7M+77.5%

Asia$68.9M+64.5%

By product

See full

Vascular$236.8M+8.1%

Interventional$204.7M+104%

Surgical$106.8M+12.4%

Competitors

By market cap

Medtronic$107.81B-8.5%

Boston Scientific$67.6B-56.8%

Becton, Dickinson and Company$43.8B-16.5%

TFX

Teleflex$5.8B+13.6%

Merit Medical Systems$4.5B-9.1%

ITG

Integer Holdings$3.4B-10.9%

AngioDynamics$564.6M+52.4%

Catheter Precision$1.0M-61.7%

By revenue growth

TFX

Teleflex+25.0%

Boston Scientific+13.5%

Merit Medical Systems+11.1%

AngioDynamics+9.5%

Medtronic+8.4%

Becton, Dickinson and Company+6.4%

ITG

Integer Holdings+6.3%

By net margin

Boston Scientific17.48%+4.0pp

Medtronic13.2%-0.7pp

Merit Medical Systems9.03%+0.2pp

ITG

Integer Holdings7.64%+3.2pp

Becton, Dickinson and Company5.33%-2.1pp

AngioDynamics-11.48%+0.1pp

TFX

Teleflex-47.43%-56.2pp

Profile

Teleflex Incorporated is a global provider of medical technology products focused on critical care and surgical applications. The company specializes in designing and manufacturing single-use medical devices that enhance clinical outcomes, improve patient safety, and reduce procedural costs for hospitals and healthcare providers. Following a strategic pivot to become a pure-play medical device entity, the company is currently undergoing a transformation to divest its Acute Care, Interventional Urology, and OEM businesses.

Competitive position

A leading global provider of high-acuity medical devices with a strong emphasis on Class I and Class II 510(k) cleared products.

GeographiesUnited States, Czech Republic, Malaysia, Mexico, Europe, Middle East, Africa, Asia Pacific

Customer segmentsHospitals, Healthcare Providers, Emergency Medical Services

Business modelManufacturing, Direct-to-hospital sales, Distributor-based distribution

SuppliersRaw material suppliers, Specialized component manufacturers, Sterilization services

CustomersHospitals, Surgical centers, Emergency medical services, Third-party medical distributors

CountryUnited States of America

Listed1972

Employees14.5K

CEOJason Weidman

SectorHealthcare

IndustryMedical - Instruments & Supplies

Websiteteleflex.com

FilingsSEC EDGAR

Ask your AI about Teleflex.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Teleflex's market cap?: Teleflex (TFX) has a market capitalization of $5.8B and trades on NYSE.
What is Teleflex's revenue and profitability?: Teleflex generated $2.1B in trailing twelve-month revenue with a net loss of $1.0B, representing a net margin of -47.4%. Gross margin stands at 38.2%, with free cash flow of $122.3M. These figures are based on the Q1 2026 filing.
Who are Teleflex's competitors?: Teleflex's key competitors include Medtronic plc, Boston Scientific Corporation, Becton, Dickinson and Company, and others. These companies compete in similar markets and product categories.
Who does Teleflex partner with?: Teleflex's notable partners include Medline Industries, Inc., Montagu, Kohlberg & Company, and others.
What subsidiaries does Teleflex have?: Teleflex's subsidiaries include BIOTRONIK SE & Co. KG (Vascular Intervention business).
Where is Teleflex headquartered?: Teleflex is headquartered in United States of America and employs approximately 14,500 people. It has been publicly traded since 1972.